Real World Evidence: Time for a Switch?
Drug Saf
.
2018 Dec;41(12):1309-1312.
doi: 10.1007/s40264-018-0739-y.
Authors
Rachel E Sobel
1
,
Andrew Bate
2
,
Robert F Reynolds
1
Affiliations
1
Pfizer Inc, Worldwide Safety and Regulatory, New York, NY, USA.
2
Pfizer Ltd, Worldwide Safety and Regulatory, Walton Oaks, UK. andrew.bate@pfizer.com.
PMID:
30302624
DOI:
10.1007/s40264-018-0739-y
No abstract available
Publication types
Comment
MeSH terms
Drugs, Generic*
United States
United States Food and Drug Administration*
Substances
Drugs, Generic